Insights

Expansion Opportunities Rosemont has actively expanded through acquisitions in Europe and Greece, including Pharmadata and a Greek CDMO, signaling a growth trajectory and potential partnership opportunities to broaden manufacturing capacity and geographic reach.

Liquidity Focus With a portfolio of over 130 oral liquid medicines and nine PEG/NG tube licensed products, there is a strong market emphasis on liquid formulations and patient-specific administration, suggesting cross-sell potential to clinicians and distributors seeking liquid alternatives.

Strategic Partnerships Historic and ongoing collaborations, including distribution agreements and regional partnerships in MENA and Canada, indicate a receptiveness to new alliances that could accelerate market access and broaden product adoption for new liquid formulations.

R&D to Commercial Recent launches such as licensed omeprazole suspension and the move from specials to licensed products demonstrate a pipeline that can be leveraged to upsell regulatory-compliant, ready-to-distribute liquids to hospital and retail channels.

Technology Enablement Investment in Microsoft Power Platform, Fabric and other digital tools suggests strong operational efficiency and data capabilities that can support customer success programs, digital order fulfillment, and streamlined regulatory documentation for sales engagements.

Similar companies to Rosemont Pharmaceuticals

Rosemont Pharmaceuticals Tech Stack

Rosemont Pharmaceuticals uses 8 technology products and services including Microsoft Power Apps, Power BI, WordPress, and more. Explore Rosemont Pharmaceuticals's tech stack below.

Media & News

Rosemont Pharmaceuticals's Email Address Formats

Rosemont Pharmaceuticals uses at least 4 email formats:
Rosemont Pharmaceuticals Email FormatsExamplePercentage
First.Last@rosemontpharma.comJohn.Doe@rosemontpharma.com
91%
F.Last@rosemontpharma.comJ.Doe@rosemontpharma.com
7%
Last@rosemontpharma.comDoe@rosemontpharma.com
1%
FLast@rosemontpharma.comJDoe@rosemontpharma.com
1%

Frequently Asked Questions

What is Rosemont Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Rosemont Pharmaceuticals's official website is rosemontpharma.com and has social profiles on LinkedIn.

How much revenue does Rosemont Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of August 2026, Rosemont Pharmaceuticals's annual revenue is estimated to be $10M - $25M.

What is Rosemont Pharmaceuticals's SIC code and NAICS code?

Minus sign iconPlus sign icon
Rosemont Pharmaceuticals's SIC code is 2834 - Pharmaceutical Preparations and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Rosemont Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of August 2026, Rosemont Pharmaceuticals has approximately 303 employees across 3 continents, including Europe, North America and Asia. Key team members include Chief People Officer: C. H., Chief Financial Officer: G. W. and Chief Marketing Officer Quality Assurance Manager: F. P. Explore Rosemont Pharmaceuticals's employee directory with LeadIQ.

What industry does Rosemont Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Rosemont Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Rosemont Pharmaceuticals use?

Minus sign iconPlus sign icon
Rosemont Pharmaceuticals's tech stack includes Microsoft Power Apps, Power BI, WordPress, Salesforce, Firebase, Google Workspace, DocuSign and Microsoft Teams.

What is Rosemont Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Rosemont Pharmaceuticals's email format typically follows the pattern of First.Last@rosemontpharma.com. Find more Rosemont Pharmaceuticals email formats with LeadIQ.
Rosemont Pharmaceuticals logo

Rosemont Pharmaceuticals

Pharmaceutical ManufacturingEngland, United Kingdom201-500 Employees

Rosemont Pharmaceuticals is a pharmaceutical manufacturing company focused on rapid development, reliable production, and global supply of novel-delivery medicines designed with patient needs in mind. The company has built a reputation for supporting patients with swallowing difficulties, advocating liquid medications over manipulation of solid-dose forms, and producing educational resources for healthcare professionals on medication management challenges. Its portfolio includes more than 130 oral liquid medicines across multiple therapeutic areas, with around 70 licensed products, and all items are manufactured to GMP standards. The UK range includes nine products licensed for use with PEG or NG tubes, and Rosemont aims to expand its licensed offerings by converting more specials where possible.

Based in Leeds, England, Rosemont operates within the pharmaceutical manufacturing industry and serves healthcare professionals and patients who rely on liquid formulations. The company positions itself as a specialized provider of liquid medicines, addressing the needs of patients with swallowing difficulties and promoting best practices in the administration of liquid medications. In August 2024, Rosemont announced an asset investment in a Greek contract development and manufacturing organization and acquired a Greek CDMO, expanding its manufacturing footprint in Southern Europe.

Section iconCompany Overview

SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
201-500

Section iconFunding & Financials

  • $10M - $25M

    Rosemont Pharmaceuticals's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.